Differentiation syndrome in patients with acute promyelocytic leukemia
journal contribution
submitted on 2025-05-20, 10:50 and posted on 2025-05-20, 10:51 authored by Nusiba H. Elamin, Farah Rashid, Muhammad S. Afana, Honar Cherif, Mohamed A. YassinA 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.
Other Information
Published in: Clinical Case Reports
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: https://dx.doi.org/10.1002/ccr3.6697
Funding
Open Access funding provided by the Qatar National Library.
History
Language
- English
Publisher
WileyPublication Year
- 2023
License statement
This Item is licensed under the Creative Commons Attribution 4.0 International License.Institution affiliated with
- Hamad Medical Corporation
- Hamad General Hospital - HMC
- National Center for Cancer Care and Research - HMC
